Background—Previous investigators have shown that systemic markers of inflammation may
be increased in patients with acute ischemic syndromes or after percutaneous coronary …

The authors examined the distribution of, and risk factors associated with, the inflammatory
marker C‐reactive protein (CRP) among a large sample of non‐institutionalized American …

Emerging evidence links an elevated baseline inflammatory status to adverse outcomes
among patients undergoing percutaneous coronary intervention (PCI). Patients with …

The first clinical trial of tissue-engineered vascular grafts (TEVGs) identified stenosis as the
primary cause of graft failure. In this study, we aimed to elucidate the role of the host immune …

Next is a granulation or cellular proliferation phase. Growth factors are subsequently
released from platelets, leukocytes, and SMCs, which stimulate migration of SMCs from the …

OBJECTIVE: To discuss the role of C-reactive protein (CRP) in cardiovascular disease as a
predictor of vascular events and identify key factors that increase or decrease this …

OBJECTIVES We sought to investigate whether statin therapy affects the association
between preprocedural C-reactive protein (CRP) levels and the risk for recurrent coronary …

Vascular grafts that can support total replacement and maintenance by the body of the
injured vessel would improve outcomes of major surgical reconstructions. Building scaffolds …

Interleukin 18 (IL-18), which is a recently cloned cytokine synthesised by KupVer cells, has
been shown to activate macrophages. 1 Macrophages and T cells have been reported to be …

Restenosis after stent implantation is mainly caused by neointimal proliferation through the
stent struts. Experimental studies performed in the last decade indicate that inflammatory …